🟢 EIQ.AX is trading 28% up today on Pro Medicus funding and US distribution deal

EIQ.AX is trading 28% up at A$1.58 after announcing a strategic funding and U.S. commercial partnership with Pro Medicus.

• The agreement provides up to A$20 million in secured convertible notes and debt, significantly strengthening the company's funding position.
• A new reseller arrangement for EchoSolv in the U.S. provides a clear commercialization pathway and supports confidence in upcoming FDA-related milestones.